In comparison, an emerging treatment with potential therapeutic application, in the form of a pentadecapeptide known as BPC 157 (body protection compound), appears to be somewhat unrestricted by the limitations seen in previous therapies
How fast depends on how low your levels were and your overall health
That said, some preclinical research has explored oral BPC-157 in the context of gastrointestinal health, where localized gut exposure may be relevant
The last approach that is rarely used by us nowadays is the interlaminar approach, which places the injection directly into the central canal between two vertebrae
Side effects appear to be infrequent and mild in most reported cases, and may include: Temporary injection site reactions (with subcutaneous administration) Mild headache in some individuals Vivid dreams often considered a sign of enhanced REM sleep activity Occasional mild gastrointestinal discomfort DSIP does not appear to suppress respiratory function or cause the cognitive impairment sometimes associated with sedative-hypnotic drugs
Musculoskeletal Healing It may accelerate healing in tendon, ligament and muscle injuries